BioNTech (BNTX)
(Real Time Quote from BATS)
$100.44 USD
+1.69 (1.71%)
Updated May 31, 2024 02:46 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 21 - 40 ( 154 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 101123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COVID-19 Vaccine Approvals; Patent Infringement Case Updates; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 82123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Revised 2023 Guidance; 2Q23 Financials; Modulating PT to $180
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Vaccine Supply Agreement With European Commission Amended; Modulating PT to $181
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple Datasets Expected at ASCO; 1Q23 Financials; Modulating PT to $198
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY Sales Expected to Significantly Decline in 2023; 4Q22 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
OncoC4 Collaboration; Bivalent Vaccine Gets New EUA; Lowering PT to $210
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R